ArticleBlood vessels, thrombosis & hemostasis2026

Emicizumab enables rapid tolerance, reducing bleeding during low-dose ITI in pediatric hemophilia A.

Carolina Costa-Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.